{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T12:26:10Z","timestamp":1754396770869},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1097\/mbc.0b013e328364b9e6","type":"journal-article","created":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T11:48:15Z","timestamp":1376394495000},"page":"848-853","source":"Crossref","is-referenced-by-count":10,"title":["Budd\u2013Chiari syndrome in very young adult patients with polycythemia vera"],"prefix":"10.1097","volume":"24","author":[{"given":"Gal","family":"Goldstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Maor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeruham","family":"Kleinbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehezkel","family":"Sidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ophira","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-9-20210203","first-page":"68","article-title":"Polycythemia Vera updated: diagnosis, pathobiology, and treatment.","volume":"51-","author":"Pearson","year":"2000","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R2-9-20210203","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0037-1963(01)90135-0","article-title":"Pathogenetic mechanisms of polycythemia vera and congenital polycythemic disorders.","volume":"38","author":"Prchal","year":"2001","journal-title":"Semin Hematol"},{"key":"R3-9-20210203","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1002\/cncr.24440","article-title":"The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos.","volume":"115","author":"Tefferi","year":"2009","journal-title":"Cancer"},{"key":"R4-9-20210203","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood.V26.3.243.243","article-title":"Polycythemia vera: age relationship and survival.","volume":"26","author":"Osgood","year":"1965","journal-title":"Blood"},{"key":"R5-9-20210203","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00277-009-0758-y","article-title":"Clinical and hematological presentation of children and adolescents with polycythemia vera.","volume":"88","author":"Cario","year":"2009","journal-title":"Ann Hematol"},{"key":"R6-9-20210203","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cld.2008.10.002","article-title":"Portal vein thrombosis and Budd-Chiari syndrome.","volume":"13","author":"Bittencourt","year":"2009","journal-title":"Clin Liver Dis"},{"key":"R7-9-20210203","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/bmj.2.5005.1343","article-title":"Diagnosis and treatment of the Budd-Chiari syndrome in polycythemia vera.","volume":"2","author":"Fitzgerald","year":"1956","journal-title":"BMJ"},{"key":"R8-9-20210203","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/hep.1840050525","article-title":"Polycythemia and the Budd-Chiari syndrome: study of serum erythropoietin and bone marrow erythroid progenitors.","volume":"5","author":"Levy","year":"1985","journal-title":"Hepatology"},{"key":"R9-9-20210203","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-103-3-329","article-title":"Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome.","volume":"103","author":"Valla","year":"1985","journal-title":"Ann Internal Med"},{"key":"R10-9-20210203","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0168-8278(97)80044-X","article-title":"Multilineage hemopoietic stem cell defects in BCS.","volume":"26","author":"Dayal","year":"1997","journal-title":"J Hepatol"},{"key":"R11-9-20210203","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1600-0609.1995.tb00703.x","article-title":"Identification of latent myeloproliferative disease in patients with Budd-Chiari syndrome using X-chromosome inactivation patterns and in vitro erythroid colony formation.","volume":"55","author":"Acharya","year":"1995","journal-title":"Eur J Haematol"},{"key":"R12-9-20210203","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1055\/s-2007-996117","article-title":"Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis.","volume":"23","author":"De Stefano","year":"1997","journal-title":"Semin Thromb Hemost"},{"key":"R13-9-20210203","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0168-8278(00)80218-4","article-title":"Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome.","volume":"32","author":"Hirshberg","year":"2000","journal-title":"J Hepatol"},{"key":"R14-9-20210203","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1182\/blood-2008-11-191544","article-title":"The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome.","volume":"113","author":"Sozer","year":"2009","journal-title":"Blood"},{"issue":"Suppl","key":"R15-9-20210203","first-page":"11","article-title":"Polycythemia vera and essential thrombocythemia in young patients.","volume":"78","author":"Frezzato","year":"1993","journal-title":"Haematologica"},{"key":"R16-9-20210203","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2141.1987.tb02349.x","article-title":"Polycythemia vera in young people: an analysis of 58 cases diagnosed before 40 years.","volume":"67","author":"Najean","year":"1987","journal-title":"Br J Haematol"},{"key":"R17-9-20210203","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2141.2008.07220.x","article-title":"Clinical and molecular characterization of characterization of a prospectively collected cohort of children and adolescents with polycythemia vera.","volume":"142","author":"Cario","year":"2008","journal-title":"Br J Haematol"},{"key":"R18-9-20210203","first-page":"543","article-title":"Is polycythemia vera a serious disease in young adults H","volume":"86","author":"Perea","year":"2001","journal-title":"aematologica"},{"key":"R19-9-20210203","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1182\/blood-2005-09-3826","article-title":"Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34 cells into peripheral blood in myeloproliferative disorders.","volume":"107","author":"Passamonti","year":"2006","journal-title":"Blood"},{"key":"R20-9-20210203","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/01.ATV.19.3.511","article-title":"Single and combined prothrombotic factors in patients with idophatic venos thromboembolism: prevalence and risk assessment.","volume":"19","author":"Salomon","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R21-9-20210203","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2214\/ajr.171.5.9798861","article-title":"CT angiography of superior mesenteric artery syndrome.","volume":"171","author":"Konen","year":"1998","journal-title":"Am J Roentgenol"},{"key":"R22-9-20210203","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1182\/blood-2011-08-371328","article-title":"Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome.","volume":"119","author":"Giona","year":"2012","journal-title":"Blood"},{"key":"R23-9-20210203","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/leu.2012.12","article-title":"How to manage children and young adults with myeloproliferative neoplasms.","volume":"26","author":"Barbui","year":"2012","journal-title":"Leukemia"},{"key":"R24-9-20210203","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/MPH.0b013e31820150bf","article-title":"JAK2V617F mutation in a 9 year old girl with polycythemia vera and Budd-Chiari syndrome: a case report.","volume":"34","author":"Benedik-Dolnicar","year":"2012","journal-title":"J Pediatr Hematol Oncol"},{"key":"R25-9-20210203","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0002-9149(98)00660-2","article-title":"Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin.","volume":"82","author":"Bates","year":"1998","journal-title":"Am J Cardiol"},{"key":"R26-9-20210203","first-page":"277","article-title":"Use of bivalirudin to prevent thrombosis following orthotopic liver transplantation in a patient with Budd-Chiari syndrome and a history of heparin-induced thrombocytopenia.","volume":"38","author":"Anderegg","year":"2008","journal-title":"Ann Clin Lab Sci"},{"key":"R27-9-20210203","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1160\/TH12-05-0319","article-title":"New direct oral anticoagulants: current therapeutic options and treatment recommendations for bleeding complications.","volume":"108","author":"Miesbach","year":"2012","journal-title":"Thromb Haemost"},{"key":"R28-9-20210203","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1182\/blood-2012-05-423228","article-title":"Perioperative management of patients on chronic antithrombotic therapy.","volume":"120","author":"Orterl","year":"2012","journal-title":"Blood"},{"key":"R29-9-20210203","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1182\/blood-2011-09-376517","article-title":"Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.","volume":"120","author":"Smalberg","year":"2012","journal-title":"Blood"},{"key":"R30-9-20210203","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1182\/blood-2006-08-042515","article-title":"European Collaboration on Low-Dose Aspirin in Polycythemia Vera (ECLAP)Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera.","volume":"109","author":"Landolfi","year":"2007","journal-title":"Blood"},{"key":"R31-9-20210203","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/S0140-6736(10)60962-2","article-title":"Risk assessment for recurrent venous thrombosis.","volume":"376","author":"Kyrle","year":"2010","journal-title":"Lancet"},{"key":"R32-9-20210203","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajh.21593","article-title":"GIMEMA Chronic Myeloproliferative Neoplasms Working PartyLeukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia.","volume":"85","author":"De Stefano","year":"2010","journal-title":"Am J Hematol"},{"key":"R33-9-20210203","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1056\/NEJM199905063401801","article-title":"Reyes syndrome in the United States from 1981 through.","volume":"340","author":"Belay","year":"1999","journal-title":"N Engl J Med"},{"key":"R34-9-20210203","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1200\/JCO.2010.31.8436","article-title":"Philadelphia negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet.","volume":"29","author":"Barbui","year":"2011","journal-title":"J Clin Oncol"},{"key":"R36-9-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajh.10153","article-title":"F Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.","volume":"71","author":"Ruggeri","year":"2002","journal-title":"Am J Hematol"},{"key":"R37-9-20210203","first-page":"2364","article-title":"Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study.","volume":"96","author":"Janssen","year":"2000","journal-title":"Blood"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MBC.0b013e328364b9e6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T12:53:37Z","timestamp":1715864017000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-201312000-00009"}},"subtitle":["report of case series with good outcome with direct thrombin inhibitor treatment"],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e328364b9e6","relation":{},"ISSN":["0957-5235"],"issn-type":[{"type":"print","value":"0957-5235"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}